Temodar and Sutent as Therapy for Melanoma

This study has been terminated.
(Funding was inadequate to continue; Companies requested closure.)
Sponsor:
Collaborators:
Pfizer
Schering-Plough
Information provided by:
Northern California Melanoma Center
ClinicalTrials.gov Identifier:
NCT00304200
First received: March 12, 2006
Last updated: February 3, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2009
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)